A0A1V1IGJ9 (A0A1V1IGJ9_HUMAN) Homo sapiens (Human)
MHC class II antigen UniProtKBInterProInteractive Modelling
266 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
6 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of HLA-DRA*01:01/HLA-DRB1*04:01 in complex with c44H10 Fab |
Heteromer P01903; P04664; | 0.0 | 1×NAG; 10×SO4; 1×NAG; | |||
| MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange |
Heteromer P01903; P04233; | 100 | 9×EDO; 1×FLC; | |||
| Crystal structure of humanized 44H10 Fab Version 22 in complex with HLA-DR (HLA-DRA*01:01/HLA-DRB1*… |
Heteromer P01903; | 100.0 | 2×NAG; 1×SO4; | |||
| Crystal structure of HLA-DR4 in complex with a HSP70 peptide |
Heteromer P01903; P9WMJ9; | 100.0 | 1×NAG; 1×NAG; | |||
| Crystal structure of HLA-DR4 presenting citrullinated Tenascin C peptide |
Heteromer P01903; P24821; | 100.0 | 2×NAG; 3×GOL; | |||
| PB TCR in complex with HLA-DR4 presenting citrullinated Tenascin C peptide |
Heteromer P01903; P24821; | 100 | 1×NAG; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8vsp.1.B | monomer | 0.74 | 64.06 | |||